HY-146998

SARS-CoV-2 3CLpro-IN-2

SARS-CoV-2 3CLpro-IN-2 (Compound 1) is a potent inhibitor of 3CL protease. SARS-CoV-2 3CLpro-IN-2 has the potential for the research of SARS-CoV-2 diseases[1].

2951.41 €

T63385-10mg

SARS-CoV-2 3CLpro-IN-2

SARS-CoV-2 3CLpro-IN-2

Ask for quotation

T63385-1g

SARS-CoV-2 3CLpro-IN-2

SARS-CoV-2 3CLpro-IN-2

Ask for quotation

HY-135856

SARS-CoV-IN-2

SARS-CoV-IN-2 is an effective inhibitor of SARS-CoV replication. SARS-CoV-IN-2 shows anti-Coronavirus activity with an EC50 of 1.9 μM in Vero cells. SARS-CoV-IN-2 inhibits the 3D7 and W2 strains of P. falciparum with IC50s of 21.5 and 30 nM; and IC90s of 51.0 and 99.9 nM; respectively. SARS-CoV-IN-2 reduces HIV-1-induced cytopathic effect with an EC50 of 2.9 μM in MT-4 cells. Antimalarial and Antiviral Activities[1].

3738.43 €

MBS5767570-10mg

SARS-CoV-IN-2

1706.39 €

MBS5767570-50mg

SARS-CoV-IN-2

4269.02 €